Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

256 results
  1. ... published></health-condition-summary><health-condition-summary ><name >Gray platelet syndrome</name><ghr-page >https://medlineplus.gov/genetics/condition/ ...
  2. ... Blood Platelet Disorder? or Bernard-Soulier Syndrome or Gray Platelet Syndrome or Platelet Storage Pool Deficien$ or Hermanski-Pudlak ... Blood Platelet Disorder? or Bernard-Soulier Syndrome or Gray Platelet Syndrome or Platelet Storage Pool Deficien$ or Hermanski-Pudlak ...
  3. ... trees together - all Tree - heading Bernard-Soulier Syndrome Gray Platelet Syndrome Platelet Storage Pool Deficiency Hermanski-Pudlak Syndrome Thrombasthenia ...
  4. ... 120 Bernard-Soulier Syndrome C15.378.140.427 Gray Platelet Syndrome C15.378.140.735 Platelet Storage Pool Deficiency ... 335 Factor XIII Deficiency C16.320.099.417 Gray Platelet Syndrome C16.320.099.500 Hemophilia A C16.320. ...
  5. ... 120...........................................Bernard-Soulier Syndrome C15.378.140.427...........................................Gray Platelet Syndrome C15.378.140.735...........................................Platelet Storage Pool Deficiency ...
  6. ... GS) (OMIM PS214450 ). Mild skin hypopigmentation and silvery gray hair are present, but platelet function is normal. Griscelli syndrome may be caused by biallelic pathogenic variants in: ...
  7. ... reversible P2Y12 PURINORECEPTOR antagonist that inhibits ADP-mediated PLATELET AGGREGATION. It is used for the prevention of THROMBOEMBOLISM by patients with ACUTE CORONARY SYNDROME or a history of MYOCARDIAL INFARCTION. Parent Heading: ...
  8. ... reversible P2Y12 PURINORECEPTOR antagonist that inhibits ADP-mediated PLATELET AGGREGATION. It is used for the prevention of THROMBOEMBOLISM by patients with ACUTE CORONARY SYNDROME or a history of MYOCARDIAL INFARCTION. Tree locations: ...
  9. NLM Digital Collections - Prevention and management of venous thromboembolism : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), October 2014
    ... protein C PE pulmonary embolism PEP Pulmonary Embolism Prevention trial PESI Pulmonary Embolism Severity Index PF4 anti-platelet factor 4 PMT percutaneous mechanical thrombectomy PT prothrombin time PS protein S PTS post-thrombotic syndrome RAM risk assessment method RCOG Royal College of ...
  10. NLM Digital Collections - Acute coronary syndrome : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), April 2016
    ... Organization for the Assessment of Strategies for Ischemic Syndromes OPTIMAAL Optimal ... Inhibition and Patient Outcomes po oral administration PURSUITthe ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last